(Q48171083)

English

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

0 references

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

Alzheimer's disease

0 references

0 references

1

object named as

Bengt Winblad

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

2

object named as

Roy W Jones

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

author name string

Yvonne Wirth

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

Albrecht Stöffler

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

Hans Jörg Möbius

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

publication date

10 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

Dementia and Geriatric Cognitive Disorders

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

24

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

20-27

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

Mapping scores onto stages: mini-mental state examination and clinical dementia rating.

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey

1 reference

https://api.crossref.org/works/10.1159%2F000102568

21 January 2018

Identifiers

10.1159/000102568

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17496417

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48171083&oldid=2188349773"